Application 090405
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS USA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LETROZOLE | LETROZOLE | TABLET; ORAL | 2.5MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Letrozole | LETROZOLE | NuCare Pharmaceuticals,Inc. | 1b408ba8-05f7-1cf1-e063-6394a90a42bc | 2024-06-19 | Warnings, Adverse reactions | Letrozole LETROZOLE |
| Letrozole | LETROZOLE | Proficient Rx LP | e1390a0d-0280-49a5-a2d4-d2e13e9952ca | 2021-07-01 | Warnings, Adverse reactions | Letrozole LETROZOLE |
| Letrozole | LETROZOLE | Natco Pharma Limited | 35c73219-c39e-4e10-b944-76009b061e79 | 2020-11-05 | Warnings, Adverse reactions | Letrozole LETROZOLE |
| Letrozole | LETROZOLE | Dr. Reddy's Laboratories Limited | 6cfd29d7-f519-7b8c-4814-07b39f367f0d | 2018-12-06 | Warnings, Adverse reactions | Letrozole LETROZOLE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.